Cobalt complexes as antiviral and antibacterial agents

Pharmaceuticals

Volumn 3, Issue 6, 2010, Pages 1711-1728

  Chang, Eddie L ^a   Simmers, Christa ^b   Knight, D Andrew ^b  

^a NAVAL RESEARCH LABORATORY   (United States)

^b Florida Institute of Technology ^*  (United States)

Author keywords

Antibacterial; Antiviral; Cobalt

Indexed keywords

ANTIVIRUS AGENT; AZITHROMYCIN; CISPLATIN; COBALT COMPLEX; COBALT DERIVATIVE; CTC 96; FAMOTIDINE; HEXAMMINECOBALT CHLORIDE; KANAMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; CHEMICAL MODIFICATION; COMPLEX FORMATION; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; HERPES SIMPLEX KERATITIS; HUMAN; KERATOCONJUNCTIVITIS; LIGAND BINDING; LIPOPHILICITY; MOLECULAR INTERACTION; NEPHROTOXICITY; NONHUMAN; OXIDATION; PARKINSON DISEASE; PEPTIC ULCER; REFLUX ESOPHAGITIS; REVIEW; STRUCTURE ACTIVITY RELATION; VIRAL EYE INFECTION; VIRUS INHIBITION; X RAY CRYSTALLOGRAPHY; ZOLLINGER ELLISON SYNDROME;

EID: 77954918661     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3061711     Document Type: Review

References (48)

1. Merchant, B. Gold, the noble metal and the paradoxes of its toxicology. Biologicals 1998, 26, 49-59.
2. Rosenberg, B. Platinum complexes for the treatment of cancer. Interdiscipl. Sci. Rev. 1978, 3, 134-147.
3. Sadler, P.J. The biological chemistry of gold. Struct. Bond. 1984, 29, 171-214.
4. Cowan, J.A. Inorganic Biochemistry, 2nd ed.; Wiley-VCH: New York, NY, USA, 1997.
5. Clark, M.J.E. Ruthenium and Other Metal Complexes in Cancer Chemotherapy; Springer-Verlag: Heidelberg, Germany, 1989.
6. Bertini, I.; Gray, H.B.; Stiefel, E.I.; Valentine, J.S. Biological Inorganic Chemistry: Structure and Reactivity; University Science Books: Sausalito, CA, USA, 2007.
7. Kobayashi, M.; Shimizu, S. Cobalt proteins. Eur. J. Biochem. 1999, 261, 1-9.
8. Hatchikian, E.C. A cobalt porphyrin containing protein reducible by hydrogenase isolated from Desulfovibrio desulfuricans (Norway). Biochem. Biophys. Res. Commun. 1981, 103, 521-530.
9. Asbell, P.A.; Epstein, S.P.; Wallace, J.A.; Epstein, D.; Stewart, C.C.; Burger, R.M. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis. Cornea 1998, 17, 550-557.
10. Takeuchi, T.; Böttcher, A.; Quezada, C.M.; Meade, T.J.; Gray, H.B. Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes. Bioorg. Med. Chem. 1999, 7, 815-819.
11. Schwartz, J.A.; Lium, E.K.; Silverstein, S.J. Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96. J. Virol. 2001, 75, 4117-4128.
12. Epstein, S.P.; Pashinsky, Y.Y.; Gershon, D.; Winicov, I.; Srivilasa, C.; Kristic, K.J.; Asbell, P.A. Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model. BMC Opthalmol. 2006, 6, 22.
13. Böttcher, A.; Takeuchi, T.; Hardcastle, K.I.; Meade, T.J.; Gray, H.B.; Cwikel, D.; Kapon M.; Dori, Z. Spectroscopy and electrochemistry of cobalt (III) Schiff base complexes. Inorg. Chem. 1997, 36, 2498-2504.
14. Redox Pharmaceutical Cooperation Home Page. http://www.redoxpharm.com/, (accessed on 25 May 2010).
15. Louie, A.Y.; Meade, T.J. A cobalt complex that selectively disrupts the structure and function of zinc fingers. Proc. Natl. Acad. Sci. USA 1998, 95, 6663-6668
16. Wooley, P.H.; Whalen, J.D. The influence of superoxide scavenging compound CTC-23 on type II collagen-induced arthritis in mice. Agents Actions 1992, 35, 273-279.
17. Gessner, R.V.; Quigley, G.J.; Wang, A.H.; van der Marel, G.A.; van Boom, J.H.; Rich, A. Structural basis for stabilization of Z-DNA by cobalt hexaammine and magnesium cations. Biochemistry 1985, 24, 237-240.
18. Delehanty, J.B.; Bongard, J.E.; Thach, D.C.; Knight, D.A.; Hickey, T.E.; Chang, E.L. Antiviral properties of cobalt(III)-complexes. Bioorg. Med. Chem. 2008, 16, 830-837.
19. Hazuda, D.J.; Felock, P.J.; Hastings, J.C.; Pramanik, B.; Wolfe, A.L. Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. J. Virol. 1997, 71, 7005-7011.
20. Hawthorne, M.F.; Young, D.C.; Wegner, P.A. Carbametallic boron hydride derivatives. I. Apparent analogs of ferrocene and ferriciniumion. J. Am. Chem. Soc. 1965, 87, 1818-1819.
21. Cígler, P.; Kožíšek, M.; Řezáčová, P.; Brynda, J.; Otwinowski, Z.; Pokorná, J.; Plešek, J.; Grüner, B.; Dolečková-Marešová, L.; Máša, M.; Sedláček, J.; Bodem, J.; Kräusslich, H.-G.; Král, V.; Konvalinka, J. From nonpeptide toward noncarbon protease inhibitors: Metallacarboranes as specific and potent inhibitors of HIV protease. Proc. Natl. Acad. Sci. USA 2005, 102, 15394-15399.
22. Řezáčová, P.; Pokorná, J.; Brynda, J.; Kožíšek, M.; Cígler, P.; Lepšík, M.; Fanfrlík, J.; Řezáč, J.; Šašková, K.G.; Sieglová, I.; Plešek, J.; Šícha, V.; Grüner, B.; Oberwinkler, H.; Sedláček, J.; Kräusslich, H.-G.; Hobza, P.; Král, V.; Konvalinka, J. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. J. Med. Chem. 2009, 52, 7132-7141.
23. Kaya, M.; Yenikaya, C.; Colak, A.T.; Colak, F. Synthesis, spectral, thermal and biological studies of Co(III) and binuclear Ni(II) complexes with a novel amine-imine-oxime ligand. Russ. J. Gen. Chem. 2008, 78, 1808-1815.
24. Canpolat, E.; Kaya, M. Synthesis, characterization of some Co(III) complexes with vic-dioxime ligands and their antimicrobial properties. Turk. J. Chem. 2004, 28, 235-242.
25. El-Ayaan, U.; Abdel-Aziz, A.A.M. Synthesis, antimicrobial activity and molecular modeling of cobalt and nickel complexes containing the bulky ligand: bis[N-(2,6-diisopropylphenyl)- imino]acenaphthene. Eur. J. Med. Chem. 2005, 40, 1214-1221.
26. Kumar, R.S.; Arunachalam, S. Synthesis, micellar properties, DNA binding and antimicrobial studies of some surfactant-cobalt(III) complexes. Biophys. Chem. 2008, 136, 136-144.
27. Nagababu, P.; Latha, J.N.L.; Pallavi, P.; Harish, S.; Satyanarayana, S. Studies on antimicrobial activity of cobalt(III) ethylenediamine complexes. Can. J. Microbiol. 2006, 52, 1247-1254.
28. Tripathi, N.; Shalini; Sharma, V.K. Synthesis, spectroscopic and structural characterization of trivalent chromium, manganese, iron and cobalt complexes with Schiff bases derived from o-vanillin. Pol. J. Chem. 2008, 82, 523-535.
29. Murukan, B.; Mohanan, K. Studies on some trivalent transition metal complexes with a bishydrazone. J. Saudi Chem. Soc. 2006, 10, 261-270.
30. Murukan, B.; Mohanan, K. Synthesis, characterization and antibacterial properties of some trivalent metal complexes with [(2-hydroxy-1-naphthaldehyde)-3-isatin]-bishydrazone. J. Enzyme Inhib. Med. Chem. 2007, 22, 65-70.
31. Keskioǧlu, E.; Güendüzalp, A.B.; Çete, S.; Hamurcu, F.; Erk, B. Cr(III), Fe(III) and Co(III) complexes of tetradentate (ONNO) Schiff base ligands: Synthesis, characterization, properties and biological activity. Spectrochim. Acta 2008, 70A, 634-640.
32. Awadallah, R.M.; Mohamed, A.E.; Ramadan, A.M. Synthesis and biocidal activity studies on solid complexes of iron(II,III), cobalt(II,III) and nickel(II) with violuric acid and dinitrosoresorcinol. J. Indian Chem. Soc. 1988, 65, 532-534.
33. Poyraz, M.; Sari, M.; Demirci, F.; Kosar, M.; Demirayak, S.; Büeyüekgüengöer, O. Synthesis, crystal structure and biological activity of 1-(1H-benzimidazol-2-yl)-ethanone thiosemicarbazone and its cobalt complex. Polyhedron 2008, 27, 2091-2096.
34. Sharma, V.K.; Srivastava, S. Synthesis and characterization of trivalent chromium, manganese, iron and cobalt complexes with Schiff bases derived from 4-amino-5-mercapto-1,2,4-triazoles. Indian J. Chem. 2006, 45A, 1368-1374.
35. Sharma, V.K.; Srivastava, S. Synthesis, magnetic and spectral studies of chromium(III), manganese(III), iron(III) and cobalt(III) complexes of thiosemicarbazones derived from benzil α-monoxime and unsubstituted/substituted thiosemicarbazides as biological agents. J. Coord. Chem. 2008, 61, 178-191.
36. Miodragović, D.U.; Bogdanović, G.A.; Miodragović, Z.M.; Radulović, M.D.; Novaković, S.B.; Kaluderović, G.N.; Kozłowski, H. Interesting coordination abilities of antiulcer drug famotidine and antimicrobial activity of drug and its cobalt(III) complex. J. Inorg. Biochem. 2006, 100, 1568-1574.
37. Hamurcu, F.; Gündüzalp, A.B.; Çete, S.; Erk, B. The synthesis, characterization and antimicrobial activity of 1,3-bis(2-thiophenecarboxamido)propane and 1,3-bis(2-furancarboxamido)propane and their Cu(II), Zn(II), Co(III) complexes. Transition Met. Chem. 2008, 33, 137-141.
38. Singh, N.K.; Singh, D.K.; Singh, J. Synthesis, characterization and biological activity of the complexes of manganese(III), cobalt(III), nickel(II), copper(II) and zinc(II) with salicylaldehyde thiobenzhydrazone. Indian J. Chem. 2001, 40A, 1064-1069.
39. Singh, N.K.; Kushawaha, S.K.; Srivastava, A.; Sodhi, A. Synthesis, characterization, and biological studies on some bivalent and trivalent transition metal complexes of N-benzoyl-N'- thiobenzhydrazide. Synth. React. Inorg. Met.-Org. Chem. 2002, 32, 1743-1758.
40. Todorović, T.R.; Bacchi, A.; Sladić, D.M.; Todorović, N.M.; Božić, T.T.; Radanović, D.D.; Filipović, N.R.; Pelizzi, G.; Andelković, K.K. Synthesis, characterization and biological activity evaluation of Pt(II), Pd(II), Co(III) and Ni(II) complexes with N-heteroaromatic selenosemicarbazones. Inorg. Chim. Acta 2009, 362, 3813-3820.
41. Navaneetha, N.; Nagarjun, P.A.; Satyanarayana, S. Study of the spectroscopic characteristics of methyl (ligand) cobaloximes and their antibacterial activity. J. Chem. Sci. 2007, 119, 29-34.
42. Keegan, G.M.; Learmonth, I.D.; Case, C. A systematic comparison of the actual, potential, and theoretical health effects of cobalt and chromium exposures from industry and surgical implants. Crit. Revs. Toxicology 2008, 38, 645-674.
43. Barceloux, D.G.; Barceloux, D. Cobalt. Clin. Toxicol. 1999, 37, 201-206.
44. Ramakrishnan, B.; Sekharudu, C.; Pan, B. Near-atomic resolution crystal structure of an A-DNA decamer d(CCCGATCGGG): Cobalt hexammine interaction with A-DNA. Acta Cryst. 2003, D59, 67-72.
45. Matulis, D.; Rouzina, I.; Bloomfield, V.A. Thermodynamics of DNA binding and condensation: Isothermal titration calorimetry and electrostatic mechanism. J. Mol. Biol. 2000, 296, 1053-1063.
46. Naura, A.S.; Sharma, R. Toxic effects of hexaammine cobalt(III) chloride on liver and kidney in mice: Implication of oxidative stress. Drug Chem. Toxicol. 2009, 32, 293-299.
47. Kalns, J. Brooks AFB, Texas, USA. Personal communication.
48. Mishra, A.; Kaushik, N.K.; Verma, A.K.; Gupta, R. Synthesis, characterization and antibacterial activity of cobalt(III) complexes with pyridine-amide ligands. Eur. J. Med. Chem. 2008, 43, 2189-2196.